NCS Multistage Q4 revenue $35.2M (-12% YoY); net income $39.6M on $40.8M litigation reversal

NCS Multistage Holdings, Inc.

Adjusted net loss $(0.9)M, adjusted EBITDA $2.5M (down from $6.4M in Q4 2022).
Full year 2023 revenue $142.5M (-8% YoY), net loss $(3.2)M, adjusted EBITDA $11.9M.
Texas legal matter settled with no cash payment by NCS; $40.8M provision reversed in Q4.
Canadian patent infringement case mediation ongoing; $1.8M in costs paid in Q4.
Outlook: 2024 revenue expected to improve, especially in U.S. and international markets.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

NCS Multistage Holdings, Inc. reported financial results for the quarter and year ended December 31, 2023.

Period: the quarter and year ended December 31, 2023
Result: reported results

Exact text from the filing

On March 7, 2024, NCS Multistage Holdings, Inc. (the “Company”) issued a press release announcing its results for the quarter and year ended December 31, 2023.

View on SEC.gov

Browse all earnings releases →

NCS Multistage Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001692427-24-000003

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.